James H. Reamer

Array ( [id] => 4175174 [patent_doc_number] => 06083973 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Methods for inhibiting mucin secretion using RAR .alpha. selective antagonists' [patent_app_type] => 1 [patent_app_number] => 9/256949 [patent_app_country] => US [patent_app_date] => 1999-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 7325 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083973.pdf [firstpage_image] =>[orig_patent_app_number] => 256949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3941192 [patent_doc_number] => 05973169 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Ipriflavone preparation process' [patent_app_type] => 1 [patent_app_number] => 9/255043 [patent_app_country] => US [patent_app_date] => 1999-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1150 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/973/05973169.pdf [firstpage_image] =>[orig_patent_app_number] => 255043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4120806 [patent_doc_number] => 06126968 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Stable compositions containing N-propargyl-1-aminoindan' [patent_app_type] => 1 [patent_app_number] => 9/043475 [patent_app_country] => US [patent_app_date] => 1999-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1828 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/126/06126968.pdf [firstpage_image] =>[orig_patent_app_number] => 043475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185261 [patent_doc_number] => 06150415 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Epoxide hydrolase complexes and methods therewith' [patent_app_type] => 1 [patent_app_number] => 9/252148 [patent_app_country] => US [patent_app_date] => 1999-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8377 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150415.pdf [firstpage_image] =>[orig_patent_app_number] => 252148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4195454 [patent_doc_number] => 06043399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Process for the preparation of cumene hydroperoxide' [patent_app_type] => 1 [patent_app_number] => 9/252596 [patent_app_country] => US [patent_app_date] => 1999-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2690 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043399.pdf [firstpage_image] =>[orig_patent_app_number] => 252596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218103 [patent_doc_number] => 06087401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Cyclopentenones, process for preparing the same, and the use thereof' [patent_app_type] => 1 [patent_app_number] => 9/230868 [patent_app_country] => US [patent_app_date] => 1999-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23912 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087401.pdf [firstpage_image] =>[orig_patent_app_number] => 230868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4238163 [patent_doc_number] => 06143787 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Pharmaceutical composition containing 4-oxo-butynic acids' [patent_app_type] => 1 [patent_app_number] => 9/230849 [patent_app_country] => US [patent_app_date] => 1999-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3348 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143787.pdf [firstpage_image] =>[orig_patent_app_number] => 230849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157626 [patent_doc_number] => 06156738 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Diabetic supplement bar' [patent_app_type] => 1 [patent_app_number] => 9/241004 [patent_app_country] => US [patent_app_date] => 1999-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2777 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156738.pdf [firstpage_image] =>[orig_patent_app_number] => 241004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099452 [patent_doc_number] => 06048874 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Parenteral metolazone formulations' [patent_app_type] => 1 [patent_app_number] => 9/237690 [patent_app_country] => US [patent_app_date] => 1999-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2924 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048874.pdf [firstpage_image] =>[orig_patent_app_number] => 237690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011231 [patent_doc_number] => 05962516 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Immunosuppressive compounds and methods' [patent_app_type] => 1 [patent_app_number] => 9/142128 [patent_app_country] => US [patent_app_date] => 1999-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 11343 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962516.pdf [firstpage_image] =>[orig_patent_app_number] => 142128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4024444 [patent_doc_number] => 05993861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => '12-hydroxy stearic acid esters, compositions based upon same and methods of using and making such compositions' [patent_app_type] => 1 [patent_app_number] => 9/233416 [patent_app_country] => US [patent_app_date] => 1999-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6878 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/993/05993861.pdf [firstpage_image] =>[orig_patent_app_number] => 233416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4175764 [patent_doc_number] => 06019874 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Separation of conjugated linoleic acids by azeotropic distillation' [patent_app_type] => 1 [patent_app_number] => 9/232902 [patent_app_country] => US [patent_app_date] => 1999-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 644 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/019/06019874.pdf [firstpage_image] =>[orig_patent_app_number] => 232902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220397 [patent_doc_number] => 06040317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Sulfonamide fibrinogen receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 9/221044 [patent_app_country] => US [patent_app_date] => 1998-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16362 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040317.pdf [firstpage_image] =>[orig_patent_app_number] => 221044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096990 [patent_doc_number] => 06096757 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Method for treating proliferative diseases' [patent_app_type] => 1 [patent_app_number] => 9/217335 [patent_app_country] => US [patent_app_date] => 1998-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 40527 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096757.pdf [firstpage_image] =>[orig_patent_app_number] => 217335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096745 [patent_doc_number] => 06096742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Polymorphic form of a tachykinin receptor antagonist' [patent_app_type] => 1 [patent_app_number] => 9/212511 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20469 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096742.pdf [firstpage_image] =>[orig_patent_app_number] => 212511 [rel_patent_id] =>[rel_patent_doc_number] =>)